Structural-formula (Cyclobenzaprine HCl Tablets A071611 1)
Cyclobenzaprine Hydrochloride Tablet, Film Coated
Product Images NDC 76420-271
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Cyclobenzaprine Hydrochloride (NDC 76420-271). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Asclemed Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Label-5mg (Cyclobenzaprine HCl Tablets A071611 2)
This document contains information regarding Cyclobenzaprine HCI tablets distributed by Enovachem for Teva Pharmaceuticals in different quantities and NDC codes. It includes lot numbers, drug status, and dosage information. Some of the packaging contains additional warnings about the storage and handling of the tablets.*
Label-7.5mg (Cyclobenzaprine HCl Tablets A071611 3)
Label-10mg (Cyclobenzaprine HCl Tablets A071611 4)
The text appears to be a list of various medications, including their NDC codes, quantities, and other details such as manufacturing company and lot numbers. There are also directions for storage, and warnings to keep out of reach of children.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
